Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal

Guillain-Barré syndrome (GBS) is a rare acute idiopathic demyelinating polyneuropathy that causes bilateral, symmetrical, and progressive weakness of muscles. AstraZeneca vaccine is a genetically modified spike glycoprotein vaccine of an adenovirus vector. GBS following the second dose of the AstraZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Acharya, Bimarsh, KC, Sabin, Karki, Shailendra, Thapa, Pratima, KC, Pooja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010811/
https://www.ncbi.nlm.nih.gov/pubmed/36923770
http://dx.doi.org/10.1097/MS9.0000000000000193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010811/
https://www.ncbi.nlm.nih.gov/pubmed/36923770
http://dx.doi.org/10.1097/MS9.0000000000000193

Ejemplares similares